1. A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts. Issue 4 (April 2018) Authors: Huet, Sarah; Tesson, Bruno; Jais, Jean-Philippe; Feldman, Andrew L; Magnano, Laura; Thomas, Emilie; Traverse-Glehen, Alexandra; Albaud, Benoit; Carrère, Marjorie; Xerri, Luc; Ansell, Stephen M; Baseggio, Lucile; Reyes, Cécile; Tarte, Karin; Boyault, Sandrine; Haioun, Corinne; Link, Brian K; Feugi... Journal: Lancet oncology Issue: Volume 19:Issue 4(2018) Page Start: 549 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A review of rituximab, the first anti-CD20 monoclonal antibody used in the treatment of B non-Hodgkin's lymphomas. (May 2015) Authors: Feugier, Pierre Journal: Future oncology Issue: Volume 11:Number 9(2015) Page Start: 1327 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network. Issue 10044 (6th August 2016) Authors: Hermine, Olivier; Hoster, Eva; Walewski, Jan; Bosly, André; Stilgenbauer, Stephan; Thieblemont, Catherine; Szymczyk, Michal; Bouabdallah, Reda; Kneba, Michael; Hallek, Michael; Salles, Gilles; Feugier, Pierre; Ribrag, Vincent; Birkmann, Josef; Forstpointner, Roswitha; Haioun, Corinne; Hänel, Math... Journal: Lancet Issue: Volume 388:Issue 10044(2016) Page Start: 565 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Amyl nitrite inhalation, a "volatile" anemia. Issue 4 (18th March 2016) Authors: Filliatre, Lauriane; Broséus, Julien; Pissard, Serge; Mekki, Chadia; Feugier, Pierre; Perrin, Julien Journal: American journal of hematology Issue: Volume 91:Issue 4(2016:Apr.) Page Start: 448 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Amyl nitrite inhalation, a "volatile" anemia. Issue 4 (June 2016) Authors: Filliatre, Lauriane; Broséus, Julien; Pissard, Serge; Mekki, Chadia; Feugier, Pierre; Perrin, Julien Journal: American journal of hematology Issue: Volume 91:Issue 4(2016:Apr.) Page Start: 448 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab. Issue 6 (24th March 2017) Authors: Huet, Sarah; Szafer‐Glusman, Edith; Tesson, Bruno; Xerri, Luc; Fairbrother, Wayne J.; Mukhyala, Kiran; Bolen, Chris; Punnoose, Elizabeth; Tonon, Laurie; Chassagne‐Clément, Catherine; Feugier, Pierre; Viari, Alain; Jardin, Fabrice; Salles, Gilles; Sujobert, Pierre Journal: American journal of hematology Issue: Volume 92:Issue 6(2017:Jun.) Page Start: 515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia‐associated autoimmune hemolytic anemia: A multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS). Issue 3 (16th January 2015) Authors: Quinquenel, Anne; Willekens, Christophe; Dupuis, Jehan; Royer, Bruno; Ysebaert, Loic; Guibert, S. De; Michallet, Anne‐Sophie; Feugier, Pierre; Guieze, Romain; Levy, Vincent; Delmer, Alain Journal: American journal of hematology Issue: Volume 90:Issue 3(2015:Mar.) Page Start: 204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Bendamustine and rituximab in elderly patients with low‐tumour burden follicular lymphoma. Results of the LYSA phase II BRIEF study. (16th August 2018) Authors: Gyan, Emmanuel; Sonet, Anne; Brice, Pauline; Anglaret, Bruno; Laribi, Kamel; Fruchart, Christophe; Tilly, Hervé; Araujo, Carla; Soubeyran, Pierre; Gonzalez, Hugo; Morineau, Nadine; Nicolas‐Virelizier, Emmanuelle; Ghesquières, Hervé; Salles, Bruno; Bouabdallah, Réda; Orfeuvre, Hubert; Fahri, Jonat... Journal: British journal of haematology Issue: Volume 183:Number 1(2018) Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial. Issue 2 (22nd July 2022) Authors: Fornecker, Luc-Matthieu; Lazarovici, Julien; Aurer, Igor; Casasnovas, René-Olivier; Gac, Anne-Claire; Bonnet, Christophe; Bouabdallah, Krimo; Feugier, Pierre; Specht, Lena; Molina, Lysiane; Touati, Mohamed; Borel, Cécile; Stamatoullas, Aspasia; Nicolas-Virelizier, Emmanuelle; Pascal, Laurent; Lug... Journal: Journal of clinical oncology Issue: Volume 41:Issue 2(2023) Page Start: 327 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials. Issue 11 (November 2015) Authors: Maraldo, Maja V; Giusti, Francesco; Vogelius, Ivan R; Lundemann, Michael; van der Kaaij, Marleen A E; Ramadan, Safaa; Meulemans, Bart; Henry-Amar, Michel; Aleman, Berthe M P; Raemaekers, John; Meijnders, Paul; Moser, Elisabeth C; Kluin-Nelemans, Hanneke C; Feugier, Pierre; Casasnovas, Olivier; Fo... Journal: Lancet Issue: Volume 2:Issue 11(2015) Page Start: e492 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗